Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

351.00
-0.4800-0.14%
Post-market: 351.000.00000.00%19:30 EDT
Volume:674.73K
Turnover:235.82M
Market Cap:40.01B
PE:62.80
High:351.94
Open:347.82
Low:346.17
Close:351.48
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:80.95M
Volume Ratio:2.46
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:7.73
PE(LYR):142.11

Loading ...

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Stock News
·
Sep 04

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies

MT Newswires Live
·
Sep 01

BeiGene Expands Access to Innovative Cancer Therapy Through New U.S. Agreement

Stock News
·
Sep 01

BeOne Medicines Reaches US Accord on Drug Access, Domestic Manufacturing

MT Newswires Live
·
Sep 01

BeOne Medicines to expand access to cancer medicines under pact with U.S.

TIPRANKS
·
Sep 01

BeOne Medicines Reports Positive Phase 3 Survival Data for Ziihera Regimens

MT Newswires Live
·
Aug 31

Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion

Deep News
·
Aug 26

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

Stock News
·
Aug 26

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live
·
Aug 25

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 25

BeOne Medicines (ONC), What Is Behind The Fresh Attention Now?

Simply Wall St.
·
Aug 19

BeOne Medicines, Foundations Renew Deal to Deliver Cancer Medicine to Poor Countries

MT Newswires Live
·
Aug 18

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Deep News
·
Aug 18

BeOne Medicines renews partnerships to expand access to Brukinsa in leukemia

TIPRANKS
·
Aug 18

BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia

Simply Wall St.
·
Aug 15

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Stock News
·
Aug 14

Beone Medicines Awards Over 40,000 Restricted Stock Units to Employees

Stock News
·
Aug 13